Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing the acquisition of gonorrhea, according to the results of the world’s largest randomized control trial (RCT) into possible efficacy, conducted by Griffith University’s Institute for Biomedicine and Glycomics and the Kirby Institute at UNSW Sydney.